https://preview.redd.it/g1kee40aqfah1.png?width=1485&format=png&auto=webp&s=7da57c28321f1606e70bf507340e3b58c8c56d31 Breaking out a huge base on strong volume, Prime Medicine is literally the leader in Genomic editing and in my opinion can see $10+ real quick. I'll be writing a heavy DD post on this soon, just giving a …
Good morning everyone, today I wanted to give you guys significant news on a company that I’ve been watching called Modular Medical ($MODD). Modular Medical is a leader in providing more accessible and affordable insulin delivery systems to the world. …
It feels like we have been walking on eggshells for months. Every time you looked at the news, geopolitical tensions were high, and everyone expected the worst for the economy. But over the last few days, things have quietly started …
# If you are unaware, GANX has a GCase program very similar to Bial, for Parkinson's disease. Some, including me, were waiting to hear back from Bial's results on whether or not to invest in GANX. Unfortunately Bial failed, and …
[PetMed Express, Inc. Confirms Receipt of Unsolicited,](https://www.globenewswire.com/news-release/2026/06/30/3319784/10002/en/PetMed-Express-Inc-Confirms-Receipt-of-Unsolicited-Non-Binding-and-Conditional-Acquisition-Proposal-from-SilverCape-Investments-Limited.html) GlobalNewswire today reported that PetMed got an offer of $3 per share currently trading at 1.88. $PETS on Nasdaq
I looked up Dr. Olamide Oladeji’s Stanford Knight-Hennessy profile after NovaRed named him Strategic Advisor for Robotics and AI. This is not a random “AI” title being stapled onto a mining story. Stanford lists him as a Knight-Hennessy Scholar and …
TLDR: OESX, a pennystock , might rise insanely if their AI product line gains more traction. Not the 50 million mcap the tape makes it look like. Orion is a steady, medium-sized Wisconsin lighting and EV company with $86M in …
It's been a frustrating couple of weeks, CXAI believers. Many of us expected more (I know I have) after the EngineRoom acquisition, the CXAI 2.0 launch, and continued momentum in enterprise AI. Instead, the stock has drifted lower, volume has …
This interview covers how Ainos is building a Smell AI platform that transforms scent signals into machine-readable Smell IDs, and why company believes scent could become an important new data for AI. It also discuss AIMD's commercial focus in semiconductor …
Been observing this stock for a while. i bet it is gonna fly before july ends. I've observe how the stock has been accumulated. And there are not much sellers left. It is currently flattening quietly and going sideways. Without …